- Company/Commercial (38)
- Litigation / Dispute Resolution (25)
- Corporate (21)
- Pharma/Biotech (20)
- Regulatory and compliance (19)
- Banking / Finance (15)
- Employment (12)
- Healthcare (8)
- Information Technology (8)
- Intellectual Property (8)
- Crime (7)
- Energy (7)
- Media/Entertainment/Sport (7)
- Financial services (6)
- Tax (6)
- Funds (5)
- Other (4)
- Telecoms (4)
- Commodities (3)
- Environment (3)
- Agriculture (2)
- Business Tax (2)
- Competition/EU (2)
- Construction (1)
- Human Rights (1)
- Immigration (1)
- Insolvency & restructuring (1)
- Insurance/reinsurance (1)
- Personal tax / Trusts (1)
- Private Equity (1)
- Suppliers (1)
- Travel and Tourism (1)
Sort By: Newest first | Oldest first
House Ways and Means chairman tax reform discussion draft — proposals that have impact on colleges and universities
The building blocks for what could eventually form the base of US tax reform include dramatic proposals that will impact universities and colleges.
The Supreme Court has issued a ruling striking down the aggregate limits on individual campaign contributions under the Federal Election Campaign Act.
The FCC has adopted two decisions that affect compliance obligations for a wide range of organisations that make or facilitate voice calls to consumers.
The Federation of American Societies for Experimental Biology (FASEB) has released recommendations regarding response to threats by animal rights extremists.
The executive order that creates the Fiscalía Especializada en Materia de Delitos Relacionados con Hechos de Corrupción has been published by the Mexican attorney-general.
FERC has issued a proposed rulemaking and two related orders designed to better align the scheduling of gas flows with the dispatch of electric generation.
There has been further escalation of EU and US sanctions resulting from the events in Ukraine, including new designations and the issuance of a new executive order (EO) on 20 March 2014.
Those who have had any involvement with Telephone Consumer Protection Act (TCPA) litigation in the last year will be unsurprised to learn that TCPA lawsuits are on the rise.
US tax reform update: House Ways and Means chairman tax reform discussion draft and new building blocks for eventual US tax reform
The last two weeks have seen significant developments in building the blocks for what could eventually form the base of US tax reform.
The FDA has distributed a revised draft guidance document titled ‘Distributing Scientific and Medical Publications on Unapproved New Uses — Recommended Practices’.
Companies in the federal supply chain have an opportunity to prepare for the expansion of government’s anti-human-trafficking rules
This update highlights the salient aspects of the proposed rules and the requirements that are likely to be of most interest to contractors.
Companies should assess their business operations and relationships in Ukraine.
FDA revises forms for submission of patent information to the Orange Book: Federal Circuit decision alters patent term adjustment
Two recent developments will affect the listing of patent information with pharmaceutical products approved by the US Food and Drug Administration.
NYAG forges new ground in scrutiny of pharmaceutical agreements with first-filer exclusivity no-challenge settlement
NYAG has reached a settlement with two drug manufacturers regarding allegations that an agreement between the firms not to challenge each other’s eligibility for regulatory exclusivity was anti-competitive.
New US cybersecurity framework issued: in wake of cyber attacks and lawsuits, how should organisations respond?
This alert summarises the framework’s key elements and suggests practical strategies organisations can use to assess whether and how to use the framework.
SEC provides expanded no-action relief from broker-dealer registration for intermediaries in private M&A transactions
The staff of the SEC’s Division of Trading and Markets issued a no-action letter on 4 February that provides guidance on how intermediaries may effect securities transactions.
Complex and costly cross-border legal disputes are projected to grow significantly in the years ahead, according to a new survey of multinational corporations.
Federal judge limits antitrust scrutiny of pharmaceutical reverse payments to settlements involving monetary transfers
A judge held that only patent settlements involving a reverse monetary payment will be subject to antitrust scrutiny under the framework articulated by the Supreme Court last year in FTC v Actavis.
On 5 February 2014, the National Labor Relations Board voted 3–2 to reissue a notice of proposed rulemaking to amend its representation election procedures.
Health, Pharmaceutical and Biotechnology Alert: HRSA issues letter discussing ADAP 340B rebates; proposed rule expected
On 3 February 2014, the Office of Pharmacy Affairs posted a letter to its 340B drug pricing program website discussing 340B rebates paid to AIDS Drug Assistance Programs.